ENTITY
Frontage Holdings

Frontage Holdings (1521 HK)

62
Analysis
Health CareChina
Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.
more
23 Jan 2020 10:32

Long Pharmaron/Short Wuxi: Take Profit Now, A-Share Pullback the Key Risk

Pharmaron, the second-largest contract research organization (CRO) in China, was listed in Hong Kong on November 28th. The deal was anchored by a...

Logo
448 Views
Share
bearishWuxi Biologics
09 Jan 2020 20:39

WuXi Biologics Placement: Pushing the Limits

Wuxi Biologics (Cayman) Inc (2269 HK) is a global one-stop biologics services provider and often referred to as CRO (contract research...

Logo
476 Views
Share
28 Nov 2019 01:41

Pharmaron Beijing: Trading Debut, Valuation Scenario Analysis

Pharmaron Beijing Co Ltd-H (3759 HK) is a global contract research organisation (CRO) and is one of the top three drug discovery service providers...

Logo
415 Views
Share
bullishMeituan
18 Nov 2019 22:40

HK Connect Flows: Close Meituan/Elong Trade with a 14.5% Profit

In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
341 Views
Share
x